The Horizons Tracker

SEPTEMBER 10, 2021

After all, when people could get your core offering for free, not only would that harm your income but it would discourage the industry from producing content and stifle innovation. Research from the University of Southern California explains why piracy wasn’t the death knell of innovation so many feared. Thriving creativity.

Innovation 81

Innovation Download Pharmaceuticals Creativity 81

Harvard Business Review

JUNE 7, 2012

The authors conclude that’s between 550 and 600 million people in developing G20 economies. for 2013, the fourth year in a row of relatively flat growth. PwC says four forces will continue to slow the rise in medical cost trend in 2013: 1. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

JUNE 7, 2012

The authors conclude that’s between 550 and 600 million people in developing G20 economies. for 2013, the fourth year in a row of relatively flat growth. PwC says four forces will continue to slow the rise in medical cost trend in 2013: 1. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs.

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

MAY 26, 2014

Four dynamics are driving this new era of health care innovation: Finally, there is a financial incentive to innovate. billion in 2013, up 39% from 2012. While we are only in the early days of the open data movement, innovative uses of data will empower new approaches to improving outcomes.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. These costs are significantly higher for U.S. But the future trajectory of U.S.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

NOVEMBER 4, 2014

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. Health Innovation'

Cost 8

Cost Committee Insurance Health Care 8